399441 生物医药
已收盘 04-30 15:00:00
资讯
新帖
简况
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 04-23
4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股
两部门：重点推动生物医药研发外包等标准化建设
金吾财讯 · 04-23
两部门：重点推动生物医药研发外包等标准化建设
招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德
证券之星 · 04-22
招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德
A股134家生物医药公司已披露年报 去年研发投入合计超604亿元
证券日报 · 04-15
A股134家生物医药公司已披露年报 去年研发投入合计超604亿元
四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业
金吾财讯 · 04-13
四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业
派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书
智通财经 · 04-09
派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书
鹭燕医药：公司未参与厦门生物医药产业链创新基金
证券之星 · 04-09
鹭燕医药：公司未参与厦门生物医药产业链创新基金
国信证券：全球生物医药投融资复苏 助推CXO行业需求向好
智通财经 · 04-08
国信证券：全球生物医药投融资复苏 助推CXO行业需求向好
全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参
每日经济新闻 · 04-08
全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参
安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药
蓝鲸财经 · 04-07
安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药
山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期
智通财经 · 04-03
山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期
派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要
智通财经 · 04-02
派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要
派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人
智通财经 · 04-01
派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人
中山的“黄金卡位战”：以侨为桥，精准落子生物医药与人工智能
21世纪经济报道 · 04-01
中山的“黄金卡位战”：以侨为桥，精准落子生物医药与人工智能
热景生物（688068）披露北京舜景生物医药技术有限公司2024年度财务报表审计报告，3月27日股价上涨20.0%
证券之星 · 03-27
热景生物（688068）披露北京舜景生物医药技术有限公司2024年度财务报表审计报告，3月27日股价上涨20.0%
生物医药板块午后再度拉升 灵康药业触及涨停
每日经济新闻 · 03-24
生物医药板块午后再度拉升 灵康药业触及涨停
派格生物医药-B(02565)发布年度业绩 研发开支5038.7万元 已成功构建覆盖七款针对慢性疾病领域的在研药物管线矩阵
智通财经 · 03-23
派格生物医药-B(02565)发布年度业绩 研发开支5038.7万元 已成功构建覆盖七款针对慢性疾病领域的在研药物管线矩阵
3月23日甘李药业跌5.78%，招商国证生物医药指数(LOF)A基金重仓该股
证券之星 · 03-23
3月23日甘李药业跌5.78%，招商国证生物医药指数(LOF)A基金重仓该股
创新“飞轮”加速转动：上海生物医药产业何以领跑全国？
证券日报 · 03-22
创新“飞轮”加速转动：上海生物医药产业何以领跑全国？
聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型
滚动播报 · 03-21
聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2143.22,"timestamp":1777532580000,"preClose":2161.86,"halted":0,"volume":500655574,"delay":0,"changeRate":-0.0086,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-18.64,"latestTime":"04-30 15:00:00","open":2155.04,"high":2172.27,"low":2134.68,"amount":19453000000,"amplitude":0.0174,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":2161.86,"symbolType":"index","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2629886570","title":"4月23日甘李药业跌9.44%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629886570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629886570?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:24","pubTimestamp":1776932643,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日甘李药业跌9.44%，收盘报59.48元，换手率3.86%，成交量21.51万手，成交额13.09亿元。重仓甘李药业的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共42家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.398，较上一交易日上涨0.45%，近一年上涨13.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300044541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239","161726","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629064450","title":"两部门：重点推动生物医药研发外包等标准化建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2629064450","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629064450?lang=zh_cn&edition=full","pubTime":"2026-04-23 12:26","pubTimestamp":1776918412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 商务部、市场监管总局印发《服务贸易标准化工作行动计划（2026—2030年）》。其中提到，加大知识产权、科技服务、地理信息、人力资源、语言、咨询、检验检测、创意设计服务等领域的标准研制力度，推动相关标准覆盖行业境内外服务提供的全链条，提升专业服务机构的国际化服务能力。提升服务外包标准化水平，重点推动生物医药研发外包、与制造业融合发展信息技术外包、服务外包企业知识产权保护等方面的标准化建设。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979745","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","399441","161726","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629069196","title":"招商基金侯昊旗下招商国证生物医药一季报最新持仓，重仓药明康德","url":"https://stock-news.laohu8.com/highlight/detail?id=2629069196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629069196?lang=zh_cn&edition=full","pubTime":"2026-04-22 07:12","pubTimestamp":1776813167,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日招商基金旗下侯昊 许荣漫管理的招商国证生物医药指数基金(LOF)公布一季报，近1年净值增长率12.57%。与上一季度相比，该基金前十大重仓股新增凯莱英，荣昌生物；其中药明康德持仓占比10.57%，为该基金第一大重仓股；智飞生物，爱美客等退出前十大重仓股；详细数据如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200013447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","BK1141","399441","LU1997245177.USD","LU1997244956.HKD","LU2242644610.SGD","LU1046422090.SGD","BK1583","BK1576","LU1808992512.USD","LU0052750758.USD","LU1934453819.USD","LU1969619763.USD","161726","LU0456842615.SGD","LU2125910500.SGD","02359","LU2488822045.USD","LU2495084118.USD","LU1979443071.USD","LU2328871848.SGD","BK0216","LU0708995583.HKD","LU0348767384.USD","LU0320764599.SGD","LU1997245094.SGD","LU2045819591.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627425790","title":"A股134家生物医药公司已披露年报 去年研发投入合计超604亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627425790","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627425790?lang=zh_cn&edition=full","pubTime":"2026-04-15 00:43","pubTimestamp":1776184980,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，截至4月14日《证券日报》记者发稿，已有134家A股生物医药上市公司披露2025年年报。整体来看，行业去年营收、净利润稳步增长，研发投入持续加大，超三成企业实现营收与净利润双增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153704919257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4585","161726","399300","399441","159982","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627483650","title":"四川：“十五五”期间打造一流生物医药创新服务体系 大力发展医药健康产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2627483650","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627483650?lang=zh_cn&edition=full","pubTime":"2026-04-13 10:36","pubTimestamp":1776047784,"startTime":"0","endTime":"0","summary":"其中提出，深入实施六大优势产业提质倍增行动，分业施策推动重点产业领域优化结构、提质升级。引导食品饮料、轻工纺织等行业以品种、质量、效率、绿色、安全为发展重点，扩大适应需求的新型消费供给。加快医学、医疗、医药融合发展，打造一流生物医药创新服务体系，大力发展医药健康产业。推动建筑业高质量发展。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDMzODA5NjAwODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","BK4581","XBI","161726","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626821185","title":"派格生物医药-B(02565)：中国证监会就本公司H股全流通申请发出备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2626821185","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626821185?lang=zh_cn&edition=full","pubTime":"2026-04-09 18:27","pubTimestamp":1775730460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，本公司已收到中国证监会就实施H股全流通而发出日期为2026年3月26日的备案通知书。根据备案通知书，本公司就合计1.02亿股未上市股份实施H股全流通向中国证监会作出的备案已经完成。倘自备案通知书日期起计12个月内未完成股份转换，且本公司仍有意进行该转换，则本公司应当向中国证监会更新备案材料。本公司将向联交所申请批准该等H股于联交所主板上市及买卖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","02565","BK4581","BK4588","XBI","399441","BK1161","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626643907","title":"鹭燕医药：公司未参与厦门生物医药产业链创新基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2626643907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626643907?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:39","pubTimestamp":1775723949,"startTime":"0","endTime":"0","summary":"证券之星消息，鹭燕医药(002788)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：您好尊敬的董秘：鹭燕医药是否有参与厦门生物医药产业链创新基金？参与资金是多少？鹭燕医药回复：公司未参与厦门生物医药产业链创新基金。公司严格履行信息披露义务，公司的重大信息请以公司公告为准，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900026151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","002788","399441","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625788996","title":"国信证券：全球生物医药投融资复苏 助推CXO行业需求向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2625788996","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625788996?lang=zh_cn&edition=full","pubTime":"2026-04-08 10:19","pubTimestamp":1775614767,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，全球生物医药投融资明确复苏，2025年融资额同比增长4%，为CXO行业注入增长动力。CDMO方面，全球药品市场的平稳增长为CDMO行业筑牢需求根基，新分子疗法的爆发式增长更开辟了核心增量空间；CRO方面，作为研发链条的核心环节，其受投融资复苏的驱动更为直接，业绩兑现的确定性与增长弹性显著增强，行业景气度持续上行。临床前CRO领域，实验动物相关订单已率先触底反弹，后续增长确定性增强。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","161726","BK0188","XBI","CXO","BK0276","BK4581","BK0028","BK4585","BK0183","002736","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625027964","title":"全球生物医药巨头阿斯利康落子广州；深圳即将启用广东首个机器人停车场丨大湾区财经早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2625027964","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625027964?lang=zh_cn&edition=full","pubTime":"2026-04-08 07:05","pubTimestamp":1775603119,"startTime":"0","endTime":"0","summary":"｜2026年4月8日星期三｜NO.1清明假期广东旅游收入超百亿元“广东发布”微信公众号4月7日消息，据初步测算，2026年清明假期三天（4月4日至6日），广东接待游客1985.1万人次，实现旅游收入104.3亿元。点评：百亿文旅收入印证广东内需韧性、消费活力、湾区磁吸效应，为一季度经济收官、二季度内需扩容打下坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604083696940526.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604083696940526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","LU2237443465.HKD","BK4007","LU0889565916.HKD","LU1829250122.USD","LU0109394709.USD","BK4585","LU2237443895.HKD","LU0058720904.USD","159983","LU0320765992.SGD","LU0289739699.SGD","LU2237443622.USD","BK4568","LU2462157665.USD","161726","IE00B3T34201.USD","ROBO","LU2237443382.USD","LU2417539215.USD","AZN","XBI","LU2456880835.USD","LU2237443978.SGD","399441","LU2237443549.SGD","BK4588","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625468984","title":"安徽省药监局：化妆品监督抽检发现多批次不合格，涉大展生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2625468984","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625468984?lang=zh_cn&edition=full","pubTime":"2026-04-07 13:22","pubTimestamp":1775539320,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月7日讯，安徽省药品监督管理局于2026年3月25日发布《2026年第1期化妆品监督抽检质量通告》，通报全省化妆品监督抽检中发现的不符合规定产品。抽检问题主要集中在微生物超标、标签标识不规范、检出禁用原料及实际成分与备案配方不符等方面。针对不合格批次，属地市场监管部门已责令相关企业立即停止销售、下架召回，并开展原因排查与整改；省药监局同步要求依法查处并公开处理结果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775539077210443845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["399441","161726","XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624631507","title":"山西证券：生物医药定位国家支柱产业 创新药持续进入爆发期","url":"https://stock-news.laohu8.com/highlight/detail?id=2624631507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624631507?lang=zh_cn&edition=full","pubTime":"2026-04-03 10:07","pubTimestamp":1775182063,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，山西证券发布研报称，2026年全国两会期间，生物医药产业成为国家政策重点支持产业。国家已将生物医药上升为新兴支柱产业，国产创新药也迎来持续的爆发阶段。国产创新药已成为生物医药产业核心发展方向，已进入持续爆发期2025年是中国创新药出海爆发式增长的一年，各项数据均创下历史新高。2026开年，中国创新药BD出海已展现出延续2025年的势头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK4588","159992","BK4581","BK0276","XBI","161726","BK1574","399441","BK1161","002500","BK4585","BK0183","BK0188","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624503214","title":"派格生物医药-B(02565):CR059相关研究摘要获美国糖尿病协会2026年科学年会接收并入选最新突破性摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2624503214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624503214?lang=zh_cn&edition=full","pubTime":"2026-04-02 19:15","pubTimestamp":1775128554,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，集团自主研发的创新候选产品CR059 相关研究摘要已获美国糖尿病协会2026年科学年会接收，并入选Late Breaking Abstract，将以海报形式展示。根据相关研究结果，CR059展现出显著减重效果、突出的降糖表现及长期表达特征，并显示出作为长效代谢疾病治疗方案的开发潜力。美国糖尿病协会科学年会是糖尿病及代谢疾病领域具有国际影响力的学术会议之一。根据会议安排，上述研究摘要将于ADA 2026年科学年会期间以海报形式展示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","XBI","161726","02565","BK1161","BK4581","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624047597","title":"派格生物医药-B(02565)：郭恩廷获委任为联席公司秘书、授权代表及法律程序代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2624047597","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624047597?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:01","pubTimestamp":1775041287,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，邹醒龙先生(邹先生)已辞任本公司联席公司秘书(联席公司秘书); 香港联合交易所有限公司证券上市规则第 3.05条项下的本公司授权代表(授权代表); 及根据香港法例第622章公司条例第16部代表本公司于香港接收法律程序文件及通知的代表(法律程序代理人)， 自 2026年4月1日起生效。自邹先生辞任联席公司秘书、授权代表及法律程序代理人后，郭恩廷女士(郭女士)已获委任为联席公司秘书、授权代表及法律程序代理人，自2026年4月1日起生效。黄一峰先生(黄先生)将继续担任另一名联席公司秘书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","BK4585","02565","BK1161","BK4588","BK4581","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624556539","title":"中山的“黄金卡位战”：以侨为桥，精准落子生物医药与人工智能","url":"https://stock-news.laohu8.com/highlight/detail?id=2624556539","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624556539?lang=zh_cn&edition=full","pubTime":"2026-04-01 10:47","pubTimestamp":1775011620,"startTime":"0","endTime":"0","summary":"依托 “工业立市、制造业当家” 的坚实基础，叠加3个千亿级、8个百亿级产业集群的完整产业链配套，中山精准卡位生物医药、人工智能等未来赛道，试图从“交通枢纽”向“产业高地”与“人才磁场”跃迁。依托通道红利，中山精准卡位生物医药、人工智能两大战略性新兴产业，以重大项目落地构建闭环产业生态。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-01/doc-inhsyfvi5068219.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-01/doc-inhsyfvi5068219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","CHAT","BK4585","161726","161631","AGIX","399441","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622841087","title":"热景生物（688068）披露北京舜景生物医药技术有限公司2024年度财务报表审计报告，3月27日股价上涨20.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622841087","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622841087?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:05","pubTimestamp":1774602302,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，热景生物报收于132.13元，较前一交易日上涨20.0%，最新总市值为122.5亿元。该股当日开盘109.08元，最高132.13元，最低107.57元，成交额达6.69亿元，换手率为5.77%。公告显示，北京舜景生物医药技术有限公司2024年度财务报表经审计，审计意见为标准无保留意见。截至2024年12月31日，公司净资产为负，累计亏损77,174,113.98元，存在持续经营能力的重大不确定性。2024年度营业收入为461,127.82元，净利润为-53,605,551.48元。主要收入来源于动物寄养服务及其他业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700034907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0239","688068"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055153","title":"生物医药板块午后再度拉升 灵康药业触及涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055153","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621055153?lang=zh_cn&edition=full","pubTime":"2026-03-24 13:17","pubTimestamp":1774329420,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月24日，生物医药板块午后再度拉升，灵康药业（维权）触及涨停，迪哲医药、共同药业、苑东生物、诚意药业跟涨。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","161726","BK4588","BK0056","BK4581","BK0033","BK4585","XBI","603669","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621776330","title":"派格生物医药-B(02565)发布年度业绩 研发开支5038.7万元 已成功构建覆盖七款针对慢性疾病领域的在研药物管线矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2621776330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621776330?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:38","pubTimestamp":1774255101,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布截至2025年12月31日止年度业绩，该集团取得其他净收入18.9万元;研发开支5038.7万元;每股基本亏损0.55元。截至本公告日期，我们在于美国及中国推进技术创新、产品管线及业务营运方面取得重大进展。截至本公告日期，派格生物已成功构建覆盖七款针对慢性疾病领域的在研药物管线矩阵。随着核心产品派达康于2025年11月成功获得上市批准，集团将全面推进其在中国市场的商业化落地工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XBI","BK1161","161726","BK4588","BK4585","02565","399441","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621775192","title":"3月23日甘李药业跌5.78%，招商国证生物医药指数(LOF)A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621775192?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:25","pubTimestamp":1774254342,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日甘李药业跌5.78%创60日新低，收盘报56.2元，换手率1.78%，成交量9.91万手，成交额5.66亿元。重仓甘李药业的前十大公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共50家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数A。招商国证生物医药指数A目前规模为67.21亿元，最新净值0.3759，较上一交易日下跌1.6%，近一年下跌3.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300024794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0239","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621748296","title":"创新“飞轮”加速转动：上海生物医药产业何以领跑全国？","url":"https://stock-news.laohu8.com/highlight/detail?id=2621748296","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621748296?lang=zh_cn&edition=full","pubTime":"2026-03-22 23:51","pubTimestamp":1774194660,"startTime":"0","endTime":"0","summary":"生物医药被称为“永不衰落的朝阳产业”——它既是守护人类健康的终极防线，也是国家科技硬实力的重要体现。而上海以其不可忽视的行业地位，被视作观察中国生物医药产业的一座样本城市。30年前，上海的本土医药企业主要以生产仿制药为主，原研创新药严重依赖外资企业。如今，记者从上海市科委获悉，2025年上海生物医药产业规模首次突破万亿元大关，生物医药制造业产值近2100亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603223679831457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","399441","161726","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621506287","title":"聚焦钢铁、化工、生物医药等重点行业 河北将培育一批工业大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2621506287","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621506287?lang=zh_cn&edition=full","pubTime":"2026-03-21 06:57","pubTimestamp":1774047420,"startTime":"0","endTime":"0","summary":"在化工行业，河北聚焦安全生产、工艺控制、配方优化、环保监测等场景，培育智能控制大模型、安全预警大模型。在生物医药行业，河北针对药物研发、质量追溯、生产管控、临床辅助等场景，培育药物研发大模型、智能质检大模型。在机器人行业，河北针对运动控制、视觉识别、人机协作、自主决策等场景，培育运动控制大模型、多模态感知大模型。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-21/doc-inhrswxz7526058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","399441","BK4581","BK4588","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777821785064,"stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0159},{"period":"3month","weight":-0.0269},{"period":"6month","weight":-0.1036},{"period":"1year","weight":0.1148},{"period":"ytd","weight":-0.0013}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}